Fresenius Kabi USA, LLC v. BioQ Pharma Incorporated > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 7, 2018 | 12 | Notice of Voluntary Dismissal (3) Docket Text: NOTICE of Voluntary Dismissal without Prejudice Pursuant to Fed.R.Civ.P. 41(a)(1)(A)(i) by Fresenius Kabi USA, LLC (Schuman, Brett) (Filed on 5/7/2018) |
| Mar 19, 2018 | 11 | Order (2) Docket Text:ORDER SETTING CASE MANAGEMENT CONFERENCE AND REQUIRING JOINT CASE MANAGEMENT CONFERENCE STATEMENT. Signed by Judge Jeffrey S. White on 3/19/18. Joint Case Management Statement due by 6/1/2018. Initial Case Management Conference set for 6/8/2018 11:00 AM in Oakland, Courtroom 5, 2nd Floor. (jjoS, COURT STAFF) (Filed on 3/19/2018) |
| Mar 16, 2018 | N/A | Clerk's Notice of Impending Reassignment - Text Only (0) Docket Text: CLERK'S NOTICE OF IMPENDING REASSIGNMENT TO A U.S. DISTRICT COURT JUDGE: The Clerk of this Court will now randomly reassign this case to a District Judge because either (1) a party has not consented to the jurisdiction of a Magistrate Judge, or (2) time is of the essence in deciding a pending judicial action for which the necessary consents to Magistrate Judge jurisdiction have not been secured. You will be informed by separate notice of the district judge to whom this case is reassigned. ALL HEARING DATES PRESENTLY SCHEDULED BEFORE THE CURRENT MAGISTRATE JUDGE ARE VACATED AND SHOULD BE RE-NOTICED FOR HEARING BEFORE THE JUDGE TO WHOM THIS CASE IS REASSIGNED. This is a text only docket entry; there is no document associated with this notice. (ofr, COURT STAFF) (Filed on 3/16/2018) |
| Mar 16, 2018 | 10 | Order Reassigning Case (1) |
| Mar 16, 2018 | 10 | Notice of Eligibility for Video Recording (1) |
| Mar 16, 2018 | 10 | Main Document (1) Docket Text:ORDER REASSIGNING CASE. Case reassigned to Judge Jeffrey S. White for all further proceedings. case is assigned to a judge who participates in the Cameras in the Courtroom Pilot Project. See General Order 65 and http://cand.uscourts.gov/cameras. Magistrate Judge Susan van Keulen no longer assigned to the case. Reassignment Order signed by Executive Committee on 3/16/2018. (Attachments: # (1) Notice of Eligibility for Video Recording)(bwS, COURT STAFF) (Filed on 3/16/2018) |
| Mar 15, 2018 | 8 | Consent/Declination to Proceed Before a US Magistrate Judge (2) Docket Text: CONSENT/DECLINATION to Proceed Before a US Magistrate Judge by Fresenius Kabi USA, LLC.. (Schuman, Brett) (Filed on 3/15/2018) |
| Mar 12, 2018 | 7 | Patent/Trademark Report (1) Docket Text: REPORT on the filing or determination of an action regarding (cc: form mailed to register). (cv, COURT STAFF) (Filed on 3/12/2018) |
| Mar 5, 2018 | N/A | Case Assigned by Intake (0) Docket Text: Case assigned to Magistrate Judge Susan van Keulen. Counsel for plaintiff or the removing party is responsible for serving the Complaint or Notice of Removal, Summons and the assigned judge's standing orders and all other new case documents upon the opposing parties. For information, visit E-Filing A New Civil Case at http://cand.uscourts.gov/ecf/caseopening. Standing orders can be downloaded from the court's web page at www.cand.uscourts.gov/judges. Upon receipt, the summons will be issued and returned electronically. Counsel is required to send chambers a copy of the initiating documents pursuant to L.R. 5-1(e)(7). A scheduling order will be sent by Notice of Electronic Filing (NEF) within two business days. Consent/Declination due by 3/19/2018. (haS, COURT STAFF) (Filed on 3/5/2018) |
| Mar 5, 2018 | 5 | Initial Case Management Scheduling Order with ADR Deadlines (2) Docket Text:Initial Case Management Scheduling Order with ADR Deadlines: Case Management Statement due by 5/29/2018. Initial Case Management Conference set for 6/5/2018 09:30 AM in San Jose, Courtroom 6, 4th Floor. (cv, COURT STAFF) (Filed on 3/5/2018) |
| Mar 5, 2018 | 6 | Summons Issued (2) Docket Text: Summons Issued as to BioQ Pharma Incorporated. (cv, COURT STAFF) (Filed on 3/5/2018) |
| Mar 2, 2018 | 1 | Complaint (9) |
| Mar 2, 2018 | 1 | Exhibit A (20) |
| Mar 2, 2018 | 1 | Civil Cover Sheet (2) |
| Mar 2, 2018 | 2 | Certificate of Interested Entities (3) Docket Text: Certificate of Interested Entities by Fresenius Kabi USA, LLC identifying Corporate Parent Fresenius Kabi USA, Inc., Other Affiliate Fresenius Se & Co. KGAA, Other Affiliate Fresenius Kabi Pharmaceuticals Holding, Inc., Other Affiliate Fresenius Kabi AG for Fresenius Kabi USA, LLC. and Corporate Disclosure Statement (Schuman, Brett) (Filed on 3/2/2018) |
| Mar 2, 2018 | 3 | Proposed Summons (2) Docket Text: Proposed Summons. (Schuman, Brett) (Filed on 3/2/2018) |
| Mar 2, 2018 | 1 | Main Document (9) Docket Text: COMPLAINT for Patent Infringement against BioQ Pharma Incorporated ( Filing fee $ 400, receipt number 0971-12157347.). Filed byFresenius Kabi USA, LLC. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(Schuman, Brett) (Filed on 3/2/2018) |
